Evidence map›Paper›PMID 36979069›Full record

ArticleBiology2023

Improved Boron Neutron Capture Therapy Using Integrin αvβ3-Targeted Long-Retention-Type Boron Carrier in a F98 Rat Glioma Model.

Kohei Tsujino, Hideki Kashiwagi, Kai Nishimura, Ryo Kayama, Kohei Yoshimura, Yusuke Fukuo, Hiroyuki Shiba, Ryo Hiramatsu, Naosuke Nonoguchi, Motomasa Furuse and 9 more

Open access · goldFull text read
In one paragraph

Article in Biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Cobaltabis(Dicarbollide) [Pharmaceuticals (Basel, Switzerland) · 2024
    Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 3 institutions in 1 country.

Kohei TsujinoDepartment of Neurosurgery, Osaka Medical and Pharmaceutical University, Osaka 569-8686, Japan.ORCID 0000-0002-2274-3214
Hideki KashiwagiDepartment of Neurosurgery, Osaka Medical and Pharmaceutical University, Osaka 569-8686, Japan.ORCID 0000-0003-3192-4065
Kai NishimuraLaboratory for Chemistry and Life Science, Institute of Innovative Research, Tokyo Institute of Technology, Yokohama 226-8503, Japan.
Ryo KayamaDepartment of Neurosurgery, Osaka Medical and Pharmaceutical University, Osaka 569-8686, Japan.
Kohei YoshimuraDepartment of Neurosurgery, Osaka Medical and Pharmaceutical University, Osaka 569-8686, Japan.ORCID 0000-0003-4612-1820
Yusuke FukuoDepartment of Neurosurgery, Osaka Medical and Pharmaceutical University, Osaka 569-8686, Japan.
Hiroyuki ShibaDepartment of Neurosurgery, Osaka Medical and Pharmaceutical University, Osaka 569-8686, Japan.
Ryo HiramatsuDepartment of Neurosurgery, Osaka Medical and Pharmaceutical University, Osaka 569-8686, Japan.ORCID 0000-0002-5581-5472
Naosuke NonoguchiDepartment of Neurosurgery, Osaka Medical and Pharmaceutical University, Osaka 569-8686, Japan.
Motomasa FuruseDepartment of Neurosurgery, Osaka Medical and Pharmaceutical University, Osaka 569-8686, Japan.
Toshihiro TakamiDepartment of Neurosurgery, Osaka Medical and Pharmaceutical University, Osaka 569-8686, Japan.
Shin-Ichi MiyatakeKansai BNCT Medical Center, Osaka Medical and Pharmaceutical University, Osaka 569-8686, Japan.
Naonori HuKansai BNCT Medical Center, Osaka Medical and Pharmaceutical University, Osaka 569-8686, Japan.
Takushi TakataInstitute for Integrated Radiation and Nuclear Science, Kyoto University, Osaka 590-0494, Japan.
Hiroki TanakaInstitute for Integrated Radiation and Nuclear Science, Kyoto University, Osaka 590-0494, Japan.
Minoru SuzukiInstitute for Integrated Radiation and Nuclear Science, Kyoto University, Osaka 590-0494, Japan.
Shinji KawabataDepartment of Neurosurgery, Osaka Medical and Pharmaceutical University, Osaka 569-8686, Japan.ORCID 0000-0001-5007-5279
Hiroyuki NakamuraLaboratory for Chemistry and Life Science, Institute of Innovative Research, Tokyo Institute of Technology, Yokohama 226-8503, Japan.ORCID 0000-0002-4511-2984
Masahiko WanibuchiDepartment of Neurosurgery, Osaka Medical and Pharmaceutical University, Osaka 569-8686, Japan.
Osaka University of Pharmaceutical Sciences · JPKyoto University · JPTokyo Institute of Technology · JP

Funding

Japan Society for the Promotion of Science JP20H03797Japan Society for the Promotion of Science JP22K09270Japan Society for the Promotion of Science JP22K16698
6 · The paper itself

Abstract

Integrin α

Indexed as

albuminbiological targetboron neutron capture therapy (BNCT)cyclic arginine-glycine-aspartatedrug delivery systemgliomaintegrin

Identifiers

PMID36979069
PMCPMC10045558
OpenAlexW4322500750

What Socratic holds

Textfull text, public
LicenceCC BY
measurements read49
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.